This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks." ...
Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 10:00 AM EDTCompany ParticipantsStéphane Bancel - CEO ...
Elon Musk says we used to find medicine like random sticks in the woods — now we can program it like an app and basically 'cure almost anything'
Biotech is starting to sound less like medicine and more like software, and SpaceX and Tesla CEO Elon Musk thinks that shift ...
Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise
Merck has rebounded 55% in the past year, driven by optimism around its post-Keytruda strategy despite the looming patent ...
Reuters
Merck's drug helps uterine cancer patients live longer in late-stage trial
May 18 (Reuters) - Merck (MRK.N), opens new tab said on Monday its experimental drug helped certain patients with uterine cancer live longer and kept their disease from worsening in ‌a late-stage ...
STAT
Merck-Kelun lung cancer drug cut risk of tumor progression by 65%, ASCO abstract shows
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Hosted on MSN
Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma
April 20 (Reuters) - Biogen said on Monday it had agreed to pay up to $850 million to acquire exclusive rights in Greater China to an experimental immune disease treatment from Chinese biotech firm TJ ...
Lilly to buy three vaccine developers for nearly $4 billion in infectious disease push
By Sriparna Roy May 26 (Reuters) - Eli Lilly said on Tuesday it will buy three vaccine developers in deals worth up to $3.8 ...
Science Daily
A forgotten drug is giving new hope to kids with a rare disease
A decades-old drug once used to treat sleeping sickness is now showing surprising promise against an ultra-rare and life-threatening genetic disorder called Bachmann-Bupp syndrome (BABS). Early ...
syracuse.com
Dear Doctor: Increased risk of heart attack with certain drugs; how worried do I need to be?
DEAR DR. ROACH: Could you please explain the percentages that are given when a study indicates an increase for a particular risk? For example, say a person with mild coronary artery disease is at an ...